Oliver Billker joined MIMS as Director in October 2018. He was previously a senior group leader at the Wellcome Trust Sanger Institute and one of the lead investigators for their PlasmoGEM Malaria Programme project. Here, he tells us a bit more about his research, and what he hopes to achieve in his time at Umeå. Billker also holds a professorship at the Department of Molecular Biology, Umeå University.

The Nordic EMBL Partnership is very pleased to announce that Professor Poul Nissen, Director of DANDRITE (Danish Research Institute of Translational Neuroscience) has been named as the third speaker of the Nordic EMBL Partnership